File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: IL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients

TitleIL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients
Authors
Issue Date2003
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/transproceed
Citation
Transplantation Proceedings, 2003, v. 35 n. 1, p. 195 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/76472
ISSN
2015 Impact Factor: 0.867
2015 SCImago Journal Rankings: 0.455
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChoy, BYen_HK
dc.contributor.authorChan, TMen_HK
dc.contributor.authorLi, FKen_HK
dc.contributor.authorLui, SLen_HK
dc.contributor.authorLo, WKen_HK
dc.contributor.authorYip, Ten_HK
dc.contributor.authorTse, KCen_HK
dc.contributor.authorLai, KNen_HK
dc.date.accessioned2010-09-06T07:21:36Z-
dc.date.available2010-09-06T07:21:36Z-
dc.date.issued2003en_HK
dc.identifier.citationTransplantation Proceedings, 2003, v. 35 n. 1, p. 195en_HK
dc.identifier.issn0041-1345en_HK
dc.identifier.urihttp://hdl.handle.net/10722/76472-
dc.languageengen_HK
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/transproceeden_HK
dc.relation.ispartofTransplantation Proceedingsen_HK
dc.rightsTransplantation Proceedings. Copyright © Elsevier Inc.en_HK
dc.subject.meshAdulten_HK
dc.subject.meshAntibodies, Monoclonal - therapeutic useen_HK
dc.subject.meshDrug Therapy, Combinationen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshGraft Rejection - epidemiologyen_HK
dc.subject.meshHumansen_HK
dc.subject.meshImmunosuppressive Agents - therapeutic useen_HK
dc.subject.meshKidney Transplantation - adverse effects - immunologyen_HK
dc.subject.meshMaleen_HK
dc.subject.meshMorbidityen_HK
dc.subject.meshPostoperative Complications - classification - epidemiology - prevention & controlen_HK
dc.subject.meshRecombinant Fusion Proteinsen_HK
dc.subject.meshRetrospective Studiesen_HK
dc.titleIL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipientsen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0041-1345&volume=35&spage=195&epage=&date=2003&atitle=IL2-Receptor+Antagonist+(Basiliximab)+Induction+Therapy+is+Associated+with+Lower+Morbidity+and+Mortality+in+Renal+Transplant+Recipientsen_HK
dc.identifier.emailChan, TM: dtmchan@hku.hken_HK
dc.identifier.emailLai, KN: knlai@hku.hken_HK
dc.identifier.authorityChan, TM=rp00394en_HK
dc.identifier.authorityLai, KN=rp00324en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0041-1345(02)03980-5en_HK
dc.identifier.pmid12591363-
dc.identifier.scopuseid_2-s2.0-0345382846en_HK
dc.identifier.hkuros81129en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0345382846&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume35en_HK
dc.identifier.issue1en_HK
dc.identifier.spage195en_HK
dc.identifier.epage195en_HK
dc.identifier.isiWOS:000181017200080-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridChoy, BY=7003465499en_HK
dc.identifier.scopusauthoridChan, TM=7402687700en_HK
dc.identifier.scopusauthoridLi, FK=55210612400en_HK
dc.identifier.scopusauthoridLui, SL=7102379130en_HK
dc.identifier.scopusauthoridLo, WK=7201502414en_HK
dc.identifier.scopusauthoridYip, T=7004283977en_HK
dc.identifier.scopusauthoridTse, KC=7102609864en_HK
dc.identifier.scopusauthoridLai, KN=7402135706en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats